Inside information pursuant to Article 17 MAR
Heidelberg Pharma AG Receives Shareholder Loan Based on an Existing Financing Commitment
Heidelberg Pharma AG today announced that it has signed a subordinated loan agreement for a total amount of EUR 15 million with its main shareholder dievini Hopp BioTech holding GmbH & Co. KG, Walldorf, Germany. The amount of the loan corresponds to the financing commitment from 21 July 2020 that will secure the company’s cash reach until mid-2021.